Simultaneous determination of methotrexate and its eight metabolites in human whole blood by capillary zone electrophoresis

J Chromatogr A. 2003 Oct 3;1014(1-2):93-101. doi: 10.1016/s0021-9673(03)00776-3.

Abstract

A simple and selective capillary electrophoretic method was established for the simultaneous determination of methotrexate (MTX), 7-hydroxymethotrexate (7-OHMTX), 2,4-diamino-N10-methylpteroic acid (DAMPA), and polyglutamate derivatives [MTX-(Glu)n, n=2-7] in whole blood. After extraction, those analytes were separated by fused-silica capillary and a running buffer containing glycine (1.2 M, pH 9.3). The quantitative ranges were 10-50 microM for each analyte. The intra- and inter-day RSD and RE values were all less than 6 and 11%, respectively. The limits of detection (S/N= 3, injection 5 s) were found to be 1 microM for MTX, 7-OHMTX, MTX-(Glu)2, MTX-(Glu)3, and MTX-(Glu)4; 3 microM for MTX-(Glu)5 and MTX-(Glu)6; 5 microM for MTX-(Glu)7, and 8 microM for DAMPA. All recoveries were greater than 94%. This method was applied to blood MTX monitoring in a patient with acute lymphoblastic leukemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / blood*
  • Electrophoresis, Capillary / methods*
  • Folic Acid Antagonists / blood*
  • Humans
  • Methotrexate / blood*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Antimetabolites, Antineoplastic
  • Folic Acid Antagonists
  • Methotrexate